ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 204 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $149,000 | -53.9% | 10,016 | -30.1% | 0.01% | -35.7% |
Q1 2022 | $323,000 | +37.4% | 14,322 | +12.6% | 0.01% | +75.0% |
Q4 2021 | $235,000 | +46.0% | 12,720 | +5.4% | 0.01% | +60.0% |
Q3 2021 | $161,000 | -43.3% | 12,070 | -21.4% | 0.01% | -50.0% |
Q2 2021 | $284,000 | +23.5% | 15,351 | +0.0% | 0.01% | +11.1% |
Q1 2021 | $230,000 | -14.2% | 15,350 | -17.2% | 0.01% | -25.0% |
Q4 2020 | $268,000 | +185.1% | 18,533 | +61.1% | 0.01% | +140.0% |
Q3 2020 | $94,000 | +17.5% | 11,504 | -2.6% | 0.01% | +25.0% |
Q2 2020 | $80,000 | -47.7% | 11,813 | -24.5% | 0.00% | -42.9% |
Q4 2019 | $153,000 | -8.4% | 15,637 | +2.6% | 0.01% | -12.5% |
Q3 2019 | $167,000 | -16.9% | 15,243 | -11.7% | 0.01% | -20.0% |
Q2 2019 | $201,000 | +12.9% | 17,257 | -7.3% | 0.01% | +11.1% |
Q1 2019 | $178,000 | +20.3% | 18,616 | +21.5% | 0.01% | 0.0% |
Q4 2018 | $148,000 | -58.4% | 15,325 | -38.6% | 0.01% | -35.7% |
Q3 2018 | $356,000 | +7.9% | 24,959 | -9.2% | 0.01% | +7.7% |
Q2 2018 | $330,000 | -9.3% | 27,500 | -6.6% | 0.01% | -7.1% |
Q1 2018 | $364,000 | -7.6% | 29,441 | +8.6% | 0.01% | -6.7% |
Q4 2017 | $394,000 | -81.5% | 27,101 | -81.9% | 0.02% | -83.0% |
Q3 2017 | $2,125,000 | +22.5% | 149,342 | +9.9% | 0.09% | +11.4% |
Q2 2017 | $1,734,000 | +17.7% | 135,875 | +16.9% | 0.08% | +19.7% |
Q1 2017 | $1,473,000 | +25.6% | 116,183 | +1.1% | 0.07% | +22.2% |
Q4 2016 | $1,173,000 | -7.9% | 114,882 | +18.8% | 0.05% | -11.5% |
Q3 2016 | $1,273,000 | +6.0% | 96,689 | +2.2% | 0.06% | +5.2% |
Q2 2016 | $1,201,000 | -0.3% | 94,584 | +3.7% | 0.06% | -6.5% |
Q1 2016 | $1,205,000 | -23.4% | 91,214 | -10.8% | 0.06% | -17.3% |
Q4 2015 | $1,574,000 | +73.3% | 102,314 | +39.7% | 0.08% | +44.2% |
Q3 2015 | $908,000 | -6.3% | 73,227 | +3.3% | 0.05% | +30.0% |
Q2 2015 | $969,000 | +15.8% | 70,866 | +1.3% | 0.04% | +21.2% |
Q1 2015 | $837,000 | -15.3% | 69,947 | -9.6% | 0.03% | -17.5% |
Q4 2014 | $988,000 | +4.3% | 77,385 | +9.6% | 0.04% | -9.1% |
Q3 2014 | $947,000 | -28.2% | 70,605 | -14.1% | 0.04% | -24.1% |
Q2 2014 | $1,319,000 | -31.9% | 82,198 | -23.5% | 0.06% | -34.1% |
Q1 2014 | $1,937,000 | +21.3% | 107,415 | +4.0% | 0.09% | +22.2% |
Q4 2013 | $1,597,000 | +48.8% | 103,306 | +43.1% | 0.07% | +26.3% |
Q3 2013 | $1,073,000 | +52.6% | 72,180 | +32.9% | 0.06% | +14.0% |
Q2 2013 | $703,000 | – | 54,325 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |